{
  "title": "Oncology_City_Quarterly",
  "slices": [
  {
      "filter": {
        "name": "ONCOLOGY_CHPA_ BRAND_1_MAPPING",
        "description": "1-3,4,5,6,7,8,9,10",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phSearchFilterImpl",
        "filt": []
      },
      "sliders": [
        {
          "title": "",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [

            ]
          }
        },
        {
          "title": "",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [

            ]
          }
        },
        {
          "title": "",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [

            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in CHPA (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime2#:timeline_2", "MAT Q#time4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7","Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7","Lilly Relevant chemo Mkt:row_7","Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2","ALIMTA    LLY:row_2","ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4","FU AN(Generic Gemzar):row_4","Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3","SAI ZHEN(Generic Alimta):row_3","Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3","Total Generic Docetaxel(Generic Taxotere):row_3","TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4","LI PU SU    JVY:row_4","ANZATAX    H1A:row_4","All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5","Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5","Total Generic Vinorelbine(Generic Navelbine):row_5","IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5","TARCEVA    ROC:row_5","CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5","AVASTIN    GTC:row_5","GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in CHPA (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime2#:timeline_2", "YTD Q#time4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7","Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7","Lilly Relevant chemo Mkt:row_7","Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2","ALIMTA    LLY:row_2","ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4","FU AN(Generic Gemzar):row_4","Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3","SAI ZHEN(Generic Alimta):row_3","Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3","Total Generic Docetaxel(Generic Taxotere):row_3","TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4","LI PU SU    JVY:row_4","ANZATAX    H1A:row_4","All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5","Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5","Total Generic Vinorelbine(Generic Navelbine):row_5","IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5","TARCEVA    ROC:row_5","CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5","AVASTIN    GTC:row_5","GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in CHPA (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime2#:timeline_2", "QTR Q#time4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7","Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7","Lilly Relevant chemo Mkt:row_7","Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2","ALIMTA    LLY:row_2","ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4","FU AN(Generic Gemzar):row_4","Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3","SAI ZHEN(Generic Alimta):row_3","Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3","Total Generic Docetaxel(Generic Taxotere):row_3","TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4","LI PU SU    JVY:row_4","ANZATAX    H1A:row_4","All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5","Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5","Total Generic Vinorelbine(Generic Navelbine):row_5","IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5","TARCEVA    ROC:row_5","CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5","AVASTIN    GTC:row_5","GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in CHPA (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common2",
                    "Growth(%):col_common1"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7","Lilly Relevant TKI Mkt:row_7","Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7","GEMZAR    LLY:row_2","ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4","YU JIE(Generic Gemzar):row_4","FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3","SAI ZHEN(Generic Alimta):row_3","Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3","Total Generic Docetaxel(Generic Taxotere):row_3","TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4","LI PU SU    JVY:row_4","ANZATAX    H1A:row_4","All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5","Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5","Total Generic Vinorelbine(Generic Navelbine):row_5","IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5","TARCEVA    ROC:row_5","CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5","AVASTIN    GTC:row_5","GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in CHPA (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common2",
                    "Growth(%):col_common1"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7","Lilly Relevant TKI Mkt:row_7","Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7","GEMZAR    LLY:row_2","ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4","YU JIE(Generic Gemzar):row_4","FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3","SAI ZHEN(Generic Alimta):row_3","Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3","Total Generic Docetaxel(Generic Taxotere):row_3","TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4","LI PU SU    JVY:row_4","ANZATAX    H1A:row_4","All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5","Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5","Total Generic Vinorelbine(Generic Navelbine):row_5","IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5","TARCEVA    ROC:row_5","CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5","AVASTIN    GTC:row_5","GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in CHPA (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common2",
                    "Growth(%):col_common1"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7","Lilly Relevant TKI Mkt:row_7","Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7","GEMZAR    LLY:row_2","ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4","YU JIE(Generic Gemzar):row_4","FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3","SAI ZHEN(Generic Alimta):row_3","Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3","Total Generic Docetaxel(Generic Taxotere):row_3","TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4","LI PU SU    JVY:row_4","ANZATAX    H1A:row_4","All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5","Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5","Total Generic Vinorelbine(Generic Navelbine):row_5","IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5","TARCEVA    ROC:row_5","CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5","AVASTIN    GTC:row_5","GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash SOM Trends in CHPA",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Oncology Mkt",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1", "Q#qtime2#:timeline_1","Q#qtime3#:timeline_1","Q#qtime4#:timeline_1","Q#qtime5#:timeline_1","Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1","Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM(%):col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "GEMZAR    LLY:row_5",
                    "ALIMTA    LLY:row_5",
                    "ZE FEI(Generic Gemzar):row_5",
                    "YU JIE(Generic Gemzar):row_5",
                    "FU AN(Generic Gemzar):row_5",
                    "Total Generic Gemcitabine(Generic Gemzar):row_5",
                    "PU LAI LE(Generic Alimta):row_5",
                    "SAI ZHEN(Generic Alimta):row_5",
                    "Total Generic Pemetrexed(Generic Alimta):row_5",
                    "TAXOTERE    AVS:row_5",
                    "Total Generic Docetaxel(Generic Taxotere):row_5",
                    "TAXOL    BMS:row_5",
                    "ABRAXANE    CC5:row_5",
                    "LI PU SU    JVY:row_5",
                    "ANZATAX    H1A:row_5",
                    "All Other Generic Paclitaxel:row_5",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]

          }
        }
      ]
    },
    {
      "filter": {
        "name": "ONCOLOGY_CHPA_ BRAND_1_MAPPING",
        "description": "11",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["Beijing",
          "Shanghai",
          "Guangzhou",
          "Chengdu",
          "Shenyang",
          "Nanjing",
          "Hangzhou",
          "Wuhan",
          "Chongqing",
          "Fuxiaquan",
          "Pearl River Delta",
          "Suzhou",
          "Tianjin",
          "Jinan",
          "Xian",
          "Zhengzhou",
          "Ningbo"
        ]
      },
      "sliders": [
        {
          "title": "  Gemzar and Alimta Key Competitors MG Performance in Beijing (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityStackedChartCommonTable",
                "mkt_display": "Oncology Mkt",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime8#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "CONMANA    Z1B:row_5",
                    "ARCEVA    ROC:row_5",
                    "IRESSA    AZN:row_5",
                    "XELODA    ROC:row_5",
                    "NAVELBINE    P.F:row_5",
                    "TAXOL    BMS:row_5",
                    "TAXOTERE    AVS:row_5",
                    "Alimta:row_5",
                    "Gemzar:row_5"
                  ]
                },
                "city" : ["Beijing",
                  "Shanghai",
                  "Guangzhou",
                  "Chengdu",
                  "Shenyang",
                  "Nanjing",
                  "Hangzhou",
                  "Wuhan",
                  "Chongqing",
                  "Fuxiaquan",
                  "Pearl River Delta",
                  "Suzhou",
                  "Tianjin",
                  "Jinan",
                  "Xian",
                  "Zhengzhou",
                  "Ningbo"]
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "mCRC 3L Market (Relevant)_CHPA_ BRAND_1_MAPPING",
        "description": "12-13,14,15,16,17",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phSearchFilterImpl",
        "filt": []
      },
      "sliders": [
        {
          "title": "",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [

            ]
          }
        },
        {
          "title": "",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [

            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in CHPA (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7","AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5","Other Oxaliplatin:row_5","XELODA             ROC:row_5",
                    "Other Capecitabine:row_5","AI LI              JSH:row_5","CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5","AVASTIN            GTC:row_5","ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5","RALTITREXED:row_5","FANG KE            HNQ:row_5","Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5","AI TAN             JSH:row_5"
                  ]
                }
              },

              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    ":col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7","AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5","Other Oxaliplatin:row_5","XELODA             ROC:row_5",
                    "Other Capecitabine:row_5","AI LI              JSH:row_5","CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5","AVASTIN            GTC:row_5","ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5","RALTITREXED:row_5","FANG KE            HNQ:row_5","Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5","AI TAN             JSH:row_5"
                  ]
                }
              }
            ]

          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in CHPA (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7","AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5","Other Oxaliplatin:row_5","XELODA             ROC:row_5",
                    "Other Capecitabine:row_5","AI LI              JSH:row_5","CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5","AVASTIN            GTC:row_5","ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5","RALTITREXED:row_5","FANG KE            HNQ:row_5","Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5","AI TAN             JSH:row_5"
                  ]
                }
              },

              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    ":col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7","AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5","Other Oxaliplatin:row_5","XELODA             ROC:row_5",
                    "Other Capecitabine:row_5","AI LI              JSH:row_5","CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5","AVASTIN            GTC:row_5","ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5","RALTITREXED:row_5","FANG KE            HNQ:row_5","Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5","AI TAN             JSH:row_5"
                  ]
                }
              }
            ]

          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in CHPA (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7","AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5","Other Oxaliplatin:row_5","XELODA             ROC:row_5",
                    "Other Capecitabine:row_5","AI LI              JSH:row_5","CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5","AVASTIN            GTC:row_5","ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5","RALTITREXED:row_5","FANG KE            HNQ:row_5","Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5","AI TAN             JSH:row_5"
                  ]
                }
              },

              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    ":col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7","AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5","Other Oxaliplatin:row_5","XELODA             ROC:row_5",
                    "Other Capecitabine:row_5","AI LI              JSH:row_5","CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5","AVASTIN            GTC:row_5","ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5","RALTITREXED:row_5","FANG KE            HNQ:row_5","Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5","AI TAN             JSH:row_5"
                  ]
                }
              }
            ]

          }
        },
        {
          "title": "Elunate and Key Competitors CASH SOM Trends in CHPA",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentTrendsChart",
                "mkt_display": "Total mCRC 3L Market (Relevant)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1", "Q#qtime2#:timeline_1","Q#qtime3#:timeline_1","Q#qtime4#:timeline_1","Q#qtime5#:timeline_1","Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1","Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM(%):col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "ELUNATE            LLY:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "AI TAN             JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "AO XIN TAN         FKU:row_5",
                    "Total Generic Oxaliplatin(Generic Eloxatin):row_5",
                    "XELODA             ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "CAMPTO             PFZ:row_5",
                    "Total Generic Irinotecan(Generic Campto):row_5",
                    "SAI WEI JIAN       NJ2:row_5",
                    "ZHONGREN FU AN     S2H:row_5",
                    "Total Generic Fluorouracil(Generic ZHONGREN FU AN):row_5",
                    "FTORAFUR           FKU:row_5",
                    "Generic Tegafur:row_5",
                    "STIVARGA           BY6:row_5"

                  ]
                }
              }
            ]

          }
        }
      ]
    },
    {
      "filter": {
        "name": "mCRC 3L Market (Indication)_CHPA_ BRAND_1_MAPPING",
        "description": "18-19,20,21,22,23",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phSearchFilterImpl",
        "filt": []
      },
      "sliders": [
        {
          "title": "",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [

            ]
          }
        },
        {
          "title": "",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [

            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in CHPA (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0,
                  0,
                  100,
                  100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30,
                  60,
                  81,
                  81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2",
                  "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title": ":col_title_common",
                  "count": [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title": ":row_title_common",
                  "display_name": [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30,
                  300,
                  81,
                  81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2",
                  "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title": ":col_title_common",
                  "count": [
                    "Mg(Mn):col_common1",
                    ":col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title": ":row_title_common",
                  "display_name": [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in CHPA (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0,
                  0,
                  100,
                  100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30,
                  60,
                  81,
                  81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2",
                  "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title": ":col_title_common",
                  "count": [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title": ":row_title_common",
                  "display_name": [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30,
                  300,
                  81,
                  81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2",
                  "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title": ":col_title_common",
                  "count": [
                    "Mg(Mn):col_common1",
                    ":col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title": ":row_title_common",
                  "display_name": [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in CHPA (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0,
                  0,
                  100,
                  100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30,
                  60,
                  81,
                  81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2",
                  "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title": ":col_title_common",
                  "count": [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title": ":row_title_common",
                  "display_name": [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30,
                  300,
                  81,
                  81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2",
                  "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title": ":col_title_common",
                  "count": [
                    "Mg(Mn):col_common1",
                    ":col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title": ":row_title_common",
                  "display_name": [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors CASH SOM Trends in CHPA",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0,
                  0,
                  100,
                  100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Total mCRC 3L Market (Indication)",
                "mkt_col": "RMB",
                "pos": [
                  30,
                  60,
                  600,
                  400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title": ":col_title_chart",
                  "count": [
                    "SOM(%):col_common3"
                  ]
                },
                "row": {
                  "title": ":row_title_chart",
                  "display_name": [
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "Tyvyt _CHPA_ BRAND_1_MAPPING",
        "description": "24-25,26-30",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phSearchFilterImpl",
        "filt": []
      },
      "sliders": [
        {
          "title": "",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [

            ]
          }
        },
        {
          "title": "",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [

            ]
          }
        },
        {
          "title": "Key Competitors DOT/CASH Performance in CHPA (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  15, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common1",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common4"
                  ]
                },
                "row": {
                  "title" : ":row_title_common1",
                  "display_name" : [
                    "Oncology Market (L01):row_7","PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },

              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  15, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common1",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common4"
                  ]
                },
                "row": {
                  "title" : ":row_title_common1",
                  "display_name" : [
                    "Oncology Market (L01):row_7","PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]

          }
        },
        {
          "title": "Key Competitors DOT/CASH Performance in CHPA (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  15, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common1",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common4"
                  ]
                },
                "row": {
                  "title" : ":row_title_common1",
                  "display_name" : [
                    "Oncology Market (L01):row_7","PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },

              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  15, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common1",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common4"
                  ]
                },
                "row": {
                  "title" : ":row_title_common1",
                  "display_name" : [
                    "Oncology Market (L01):row_7","PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]

          }
        },
        {
          "title": "Key Competitors DOT/CASH Performance in CHPA (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  15, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common1",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common4"
                  ]
                },
                "row": {
                  "title" : ":row_title_common1",
                  "display_name" : [
                    "Oncology Market (L01):row_7","PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },

              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  15, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common1",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common4"
                  ]
                },
                "row": {
                  "title" : ":row_title_common1",
                  "display_name" : [
                    "Oncology Market (L01):row_7","PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]

          }
        },
        {
          "title": "TYVYT and Key Competitors CASH SOM Trends in Oncology market",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Oncology Market (L01)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1", "Q#qtime2#:timeline_1","Q#qtime3#:timeline_1","Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1","Q#qtime6#:timeline_1","Q#qtime7#:timeline_1","Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM(%):col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]

          }
        },
        {
          "title": "TYVYT and Key Competitors CASH SOM Trends in PD-1 Market",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "PD-1 Market",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1", "Q#qtime2#:timeline_1","Q#qtime3#:timeline_1","Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1","Q#qtime6#:timeline_1","Q#qtime7#:timeline_1","Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM(%):col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"

                  ]
                }
              }
            ]

          }
        }
      ]
    },
    {
      "filter": {
        "name": "ONCOLOGY_CHPA_ BRAND_1_MAPPING",
        "description": "31-33,34-40",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["xian"]
      },
      "sliders": [
        {
          "title": "",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [

            ]
          }
        },
        {
          "title": "",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [

            ]
          }
        },
        {
          "title": "",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [

            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Xi’an (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Xi’an (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Xi’an (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Xi’an (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Xi’an (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Xi’an (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash SOM Trends in Xi’an",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Oncology Mkt",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "GEMZAR    LLY:row_5",
                    "ALIMTA    LLY:row_5",
                    "ZE FEI(Generic Gemzar):row_5",
                    "YU JIE(Generic Gemzar):row_5",
                    "FU AN(Generic Gemzar):row_5",
                    "Total Generic Gemcitabine(Generic Gemzar):row_5",
                    "PU LAI LE(Generic Alimta):row_5",
                    "SAI ZHEN(Generic Alimta):row_5",
                    "Total Generic Pemetrexed(Generic Alimta):row_5",
                    "TAXOTERE    AVS:row_5",
                    "Total Generic Docetaxel(Generic Taxotere):row_5",
                    "TAXOL    BMS:row_5",
                    "ABRAXANE    CC5:row_5",
                    "LI PU SU    JVY:row_5",
                    "ANZATAX    H1A:row_5",
                    "All Other Generic Paclitaxel:row_5",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "mCRC 3L Market (Relevant)_CHPA_ BRAND_1_MAPPING",
        "description": "41,42-45",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["xian"]
      },
      "sliders": [
        {
          "title": "",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [

            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Xi’an (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Xi’an (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Xi’an (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors Cash SOM Trends in Xi’an",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Total mCRC 3L Market (Relevant)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "ELUNATE            LLY:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "AI TAN             JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "AO XIN TAN         FKU:row_5",
                    "Total Generic Oxaliplatin(Generic Eloxatin):row_5",
                    "XELODA             ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "CAMPTO             PFZ:row_5",
                    "Total Generic Irinotecan(Generic Campto):row_5",
                    "SAI WEI JIAN       NJ2:row_5",
                    "ZHONGREN FU AN     S2H:row_5",
                    "Total Generic Fluorouracil(Generic ZHONGREN FU AN):row_5",
                    "FTORAFUR           FKU:row_5",
                    "Generic Tegafur:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "mCRC 3L Market (Indication)_CHPA_ BRAND_1_MAPPING",
        "description": "46,47,47-50",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["xian"]
      },
      "sliders": [
        {
          "title": "",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [

            ]
          }
        },
        {
          "title": "",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [

            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Xi’an (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Xi’an (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Xi’an (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors Cash SOM Trends in Xi’an",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Total mCRC 3L Market (Indication)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "ELUNATE            LLY:row_5",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "Tyvyt _CHPA_ BRAND_1_MAPPING",
        "description": "51,52-56",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["xian"]
      },
      "sliders": [
        {
          "title": "",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [

            ]
          }
        },
        {
          "title": "Key Competitors DOT/CASH Performance in Xi’an (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Key Competitors DOT/CASH Performance in Xi’an (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Key Competitors DOT/CASH Performance in Xi’an (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "TYVYT and Key Competitors Cash SOM Trends in Xi’an Oncology market",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Oncology Market (L01)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "TYVYT and Key Competitors Cash SOM Trends in Xi’an PD-1 market",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "PD-1 Market",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "ONCOLOGY_CHPA_ BRAND_1_MAPPING",
        "description": "57,58,59-65",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["beijing"]
      },
      "sliders": [
        {
          "title": "",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [

            ]
          }
        },
        {
          "title": "",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [

            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Beijing (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Beijing (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Beijing (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Beijing (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Beijing (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Beijing (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash SOM Trends in Beijing",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Oncology Mkt",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "GEMZAR    LLY:row_5",
                    "ALIMTA    LLY:row_5",
                    "ZE FEI(Generic Gemzar):row_5",
                    "YU JIE(Generic Gemzar):row_5",
                    "FU AN(Generic Gemzar):row_5",
                    "Total Generic Gemcitabine(Generic Gemzar):row_5",
                    "PU LAI LE(Generic Alimta):row_5",
                    "SAI ZHEN(Generic Alimta):row_5",
                    "Total Generic Pemetrexed(Generic Alimta):row_5",
                    "TAXOTERE    AVS:row_5",
                    "Total Generic Docetaxel(Generic Taxotere):row_5",
                    "TAXOL    BMS:row_5",
                    "ABRAXANE    CC5:row_5",
                    "LI PU SU    JVY:row_5",
                    "ANZATAX    H1A:row_5",
                    "All Other Generic Paclitaxel:row_5",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "mCRC 3L Market (Relevant)_CHPA_ BRAND_1_MAPPING",
        "description": "66,67-70",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["beijing"]
      },
      "sliders": [
        {
          "title": "",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [

            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Beijing (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Beijing (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Beijing (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors Cash SOM Trends in Beijing",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Total mCRC 3L Market (Relevant)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "ELUNATE            LLY:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "AI TAN             JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "AO XIN TAN         FKU:row_5",
                    "Total Generic Oxaliplatin(Generic Eloxatin):row_5",
                    "XELODA             ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "CAMPTO             PFZ:row_5",
                    "Total Generic Irinotecan(Generic Campto):row_5",
                    "SAI WEI JIAN       NJ2:row_5",
                    "ZHONGREN FU AN     S2H:row_5",
                    "Total Generic Fluorouracil(Generic ZHONGREN FU AN):row_5",
                    "FTORAFUR           FKU:row_5",
                    "Generic Tegafur:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "mCRC 3L Market (Indication)_CHPA_ BRAND_1_MAPPING",
        "description": "72-75",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["beijing"]
      },
      "sliders": [
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Beijing (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Beijing (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Beijing (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors Cash SOM Trends in Beijing",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Total mCRC 3L Market (Indication)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "ELUNATE            LLY:row_5",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "Tyvyt _CHPA_ BRAND_1_MAPPING",
        "description": "77-81",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["beijing"]
      },
      "sliders": [
        {
          "title": "Key Competitors DOT/CASH Performance in Beijing (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Key Competitors DOT/CASH Performance in Beijing (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Key Competitors DOT/CASH Performance in Beijing (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "TYVYT and Key Competitors Cash SOM Trends in Beijing Oncology market",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Oncology Market (L01)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "TYVYT and Key Competitors Cash SOM Trends in Beijing PD-1 market",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "PD-1 Market",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "ONCOLOGY_CHPA_ BRAND_1_MAPPING",
        "description": "82,84-90",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["shanghai"]
      },
      "sliders": [
        {
          "title": "Shnaghai",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [

            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Shanghai (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Shanghai (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Shanghai (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Shanghai (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Shanghai (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Shanghai (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash SOM Trends in Shanghai",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Oncology Mkt",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "GEMZAR    LLY:row_5",
                    "ALIMTA    LLY:row_5",
                    "ZE FEI(Generic Gemzar):row_5",
                    "YU JIE(Generic Gemzar):row_5",
                    "FU AN(Generic Gemzar):row_5",
                    "Total Generic Gemcitabine(Generic Gemzar):row_5",
                    "PU LAI LE(Generic Alimta):row_5",
                    "SAI ZHEN(Generic Alimta):row_5",
                    "Total Generic Pemetrexed(Generic Alimta):row_5",
                    "TAXOTERE    AVS:row_5",
                    "Total Generic Docetaxel(Generic Taxotere):row_5",
                    "TAXOL    BMS:row_5",
                    "ABRAXANE    CC5:row_5",
                    "LI PU SU    JVY:row_5",
                    "ANZATAX    H1A:row_5",
                    "All Other Generic Paclitaxel:row_5",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "mCRC 3L Market (Relevant)_CHPA_ BRAND_1_MAPPING",
        "description": "92-95",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["shanghai"]
      },
      "sliders": [
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Shanghai (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Shanghai (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Shanghai (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors Cash SOM Trends in Shanghai",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Total mCRC 3L Market (Relevant)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "ELUNATE            LLY:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "AI TAN             JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "AO XIN TAN         FKU:row_5",
                    "Total Generic Oxaliplatin(Generic Eloxatin):row_5",
                    "XELODA             ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "CAMPTO             PFZ:row_5",
                    "Total Generic Irinotecan(Generic Campto):row_5",
                    "SAI WEI JIAN       NJ2:row_5",
                    "ZHONGREN FU AN     S2H:row_5",
                    "Total Generic Fluorouracil(Generic ZHONGREN FU AN):row_5",
                    "FTORAFUR           FKU:row_5",
                    "Generic Tegafur:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "mCRC 3L Market (Indication)_CHPA_ BRAND_1_MAPPING",
        "description": "97-100",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["shanghai"]
      },
      "sliders": [
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Shanghai (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Shanghai (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Shanghai (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors Cash SOM Trends in Shanghai",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Total mCRC 3L Market (Indication)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "ELUNATE            LLY:row_5",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "Tyvyt _CHPA_ BRAND_1_MAPPING",
        "description": "102-106",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["shanghai"]
      },
      "sliders": [
        {
          "title": "Key Competitors DOT/CASH Performance in Shanghai (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Key Competitors DOT/CASH Performance in Shanghai (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Key Competitors DOT/CASH Performance in Shanghai (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "TYVYT and Key Competitors Cash SOM Trends in Shanghai Oncology market",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Oncology Market (L01)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "TYVYT and Key Competitors Cash SOM Trends in Shanghai PD-1 market",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "PD-1 Market",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "ONCOLOGY_CHPA_ BRAND_1_MAPPING",
        "description": "107,109-115",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["guangzhou"]
      },
      "sliders": [
        {
          "title": "guangzhou",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [

            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Guangzhou (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Guangzhou (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Guangzhou (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Guangzhou (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Guangzhou (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Guangzhou (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash SOM Trends in Guangzhou",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Oncology Mkt",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "GEMZAR    LLY:row_5",
                    "ALIMTA    LLY:row_5",
                    "ZE FEI(Generic Gemzar):row_5",
                    "YU JIE(Generic Gemzar):row_5",
                    "FU AN(Generic Gemzar):row_5",
                    "Total Generic Gemcitabine(Generic Gemzar):row_5",
                    "PU LAI LE(Generic Alimta):row_5",
                    "SAI ZHEN(Generic Alimta):row_5",
                    "Total Generic Pemetrexed(Generic Alimta):row_5",
                    "TAXOTERE    AVS:row_5",
                    "Total Generic Docetaxel(Generic Taxotere):row_5",
                    "TAXOL    BMS:row_5",
                    "ABRAXANE    CC5:row_5",
                    "LI PU SU    JVY:row_5",
                    "ANZATAX    H1A:row_5",
                    "All Other Generic Paclitaxel:row_5",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "mCRC 3L Market (Relevant)_CHPA_ BRAND_1_MAPPING",
        "description": "117-120",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["guangzhou"]
      },
      "sliders": [
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Guangzhou (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Guangzhou (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Guangzhou (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors Cash SOM Trends in Guangzhou",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Total mCRC 3L Market (Relevant)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "ELUNATE            LLY:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "AI TAN             JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "AO XIN TAN         FKU:row_5",
                    "Total Generic Oxaliplatin(Generic Eloxatin):row_5",
                    "XELODA             ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "CAMPTO             PFZ:row_5",
                    "Total Generic Irinotecan(Generic Campto):row_5",
                    "SAI WEI JIAN       NJ2:row_5",
                    "ZHONGREN FU AN     S2H:row_5",
                    "Total Generic Fluorouracil(Generic ZHONGREN FU AN):row_5",
                    "FTORAFUR           FKU:row_5",
                    "Generic Tegafur:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "mCRC 3L Market (Indication)_CHPA_ BRAND_1_MAPPING",
        "description": "122-125",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["guangzhou"]
      },
      "sliders": [
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Guangzhou (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Guangzhou (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Guangzhou (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors Cash SOM Trends in Guangzhou",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Total mCRC 3L Market (Indication)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "ELUNATE            LLY:row_5",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "Tyvyt _CHPA_ BRAND_1_MAPPING",
        "description": "127-131",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["guangzhou"]
      },
      "sliders": [
        {
          "title": "Key Competitors DOT/CASH Performance in Guangzhou (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Key Competitors DOT/CASH Performance in Guangzhou (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Key Competitors DOT/CASH Performance in Guangzhou (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "TYVYT and Key Competitors Cash SOM Trends in Guangzhou Oncology market",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Oncology Market (L01)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "TYVYT and Key Competitors Cash SOM Trends in Guangzhou PD-1 market",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "PD-1 Market",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "ONCOLOGY_CHPA_ BRAND_1_MAPPING",
        "description": "132,134-140",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["pearl river"]
      },
      "sliders": [
        {
          "title": "PR",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [

            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Pearl River Delta (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Pearl River Delta (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Pearl River Delta (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Pearl River Delta (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Pearl River Delta (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Pearl River Delta (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash SOM Trends in Pearl River Delta",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Oncology Mkt",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "GEMZAR    LLY:row_5",
                    "ALIMTA    LLY:row_5",
                    "ZE FEI(Generic Gemzar):row_5",
                    "YU JIE(Generic Gemzar):row_5",
                    "FU AN(Generic Gemzar):row_5",
                    "Total Generic Gemcitabine(Generic Gemzar):row_5",
                    "PU LAI LE(Generic Alimta):row_5",
                    "SAI ZHEN(Generic Alimta):row_5",
                    "Total Generic Pemetrexed(Generic Alimta):row_5",
                    "TAXOTERE    AVS:row_5",
                    "Total Generic Docetaxel(Generic Taxotere):row_5",
                    "TAXOL    BMS:row_5",
                    "ABRAXANE    CC5:row_5",
                    "LI PU SU    JVY:row_5",
                    "ANZATAX    H1A:row_5",
                    "All Other Generic Paclitaxel:row_5",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "mCRC 3L Market (Relevant)_CHPA_ BRAND_1_MAPPING",
        "description": "142-145",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["pearl river"]
      },
      "sliders": [
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Pearl River Delta (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Pearl River Delta (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Pearl River Delta (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors Cash SOM Trends in Pearl River Delta",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Total mCRC 3L Market (Relevant)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "ELUNATE            LLY:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "AI TAN             JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "AO XIN TAN         FKU:row_5",
                    "Total Generic Oxaliplatin(Generic Eloxatin):row_5",
                    "XELODA             ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "CAMPTO             PFZ:row_5",
                    "Total Generic Irinotecan(Generic Campto):row_5",
                    "SAI WEI JIAN       NJ2:row_5",
                    "ZHONGREN FU AN     S2H:row_5",
                    "Total Generic Fluorouracil(Generic ZHONGREN FU AN):row_5",
                    "FTORAFUR           FKU:row_5",
                    "Generic Tegafur:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "mCRC 3L Market (Indication)_CHPA_ BRAND_1_MAPPING",
        "description": "147-150",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["pearl river"]
      },
      "sliders": [
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Pearl River Delta (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Pearl River Delta (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Pearl River Delta (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors Cash SOM Trends in Pearl River Delta",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Total mCRC 3L Market (Indication)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "ELUNATE            LLY:row_5",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "Tyvyt _CHPA_ BRAND_1_MAPPING",
        "description": "152-156",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["pearl river"]
      },
      "sliders": [
        {
          "title": "Key Competitors DOT/CASH Performance in Pearl River Delta (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Key Competitors DOT/CASH Performance in Pearl River Delta (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Key Competitors DOT/CASH Performance in Pearl River Delta (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "TYVYT and Key Competitors Cash SOM Trends in Pearl River Delta Oncology market",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Oncology Market (L01)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "TYVYT and Key Competitors Cash SOM Trends in Pearl River Delta PD-1 market",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "PD-1 Market",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "ONCOLOGY_CHPA_ BRAND_1_MAPPING",
        "description": "157,159-165",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["fuxiaquan"]
      },
      "sliders": [
        {
          "title": "FXQ",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [

            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Fuxiaquan (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Fuxiaquan (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Fuxiaquan (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Fuxiaquan (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Fuxiaquan (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Fuxiaquan (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash SOM Trends in Fuxiaquan",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Oncology Mkt",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "GEMZAR    LLY:row_5",
                    "ALIMTA    LLY:row_5",
                    "ZE FEI(Generic Gemzar):row_5",
                    "YU JIE(Generic Gemzar):row_5",
                    "FU AN(Generic Gemzar):row_5",
                    "Total Generic Gemcitabine(Generic Gemzar):row_5",
                    "PU LAI LE(Generic Alimta):row_5",
                    "SAI ZHEN(Generic Alimta):row_5",
                    "Total Generic Pemetrexed(Generic Alimta):row_5",
                    "TAXOTERE    AVS:row_5",
                    "Total Generic Docetaxel(Generic Taxotere):row_5",
                    "TAXOL    BMS:row_5",
                    "ABRAXANE    CC5:row_5",
                    "LI PU SU    JVY:row_5",
                    "ANZATAX    H1A:row_5",
                    "All Other Generic Paclitaxel:row_5",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "mCRC 3L Market (Relevant)_CHPA_ BRAND_1_MAPPING",
        "description": "167-170",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["fuxiaquan"]
      },
      "sliders": [
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Fuxiaquan (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Fuxiaquan (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Fuxiaquan (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors Cash SOM Trends in Fuxiaquan",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Total mCRC 3L Market (Relevant)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "ELUNATE            LLY:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "AI TAN             JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "AO XIN TAN         FKU:row_5",
                    "Total Generic Oxaliplatin(Generic Eloxatin):row_5",
                    "XELODA             ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "CAMPTO             PFZ:row_5",
                    "Total Generic Irinotecan(Generic Campto):row_5",
                    "SAI WEI JIAN       NJ2:row_5",
                    "ZHONGREN FU AN     S2H:row_5",
                    "Total Generic Fluorouracil(Generic ZHONGREN FU AN):row_5",
                    "FTORAFUR           FKU:row_5",
                    "Generic Tegafur:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "mCRC 3L Market (Indication)_CHPA_ BRAND_1_MAPPING",
        "description": "172-175",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["fuxiaquan"]
      },
      "sliders": [
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Fuxiaquan (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Fuxiaquan (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Fuxiaquan (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors Cash SOM Trends in Fuxiaquan",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Total mCRC 3L Market (Indication)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "ELUNATE            LLY:row_5",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "Tyvyt _CHPA_ BRAND_1_MAPPING",
        "description": "177-181",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["fuxiaquan"]
      },
      "sliders": [
        {
          "title": "Key Competitors DOT/CASH Performance in Fuxiaquan (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Key Competitors DOT/CASH Performance in Fuxiaquan (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Key Competitors DOT/CASH Performance in Fuxiaquan (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "TYVYT and Key Competitors Cash SOM Trends in Fuxiaquan Oncology market",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Oncology Market (L01)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "TYVYT and Key Competitors Cash SOM Trends in Fuxiaquan PD-1 market",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "PD-1 Market",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "ONCOLOGY_CHPA_ BRAND_1_MAPPING",
        "description": "182,184-190",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["hangzhou"]
      },
      "sliders": [
        {
          "title": "HZ",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [

            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Hangzhou (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Hangzhou (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Hangzhou (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Hangzhou (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Hangzhou (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Hangzhou (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash SOM Trends in Hangzhou",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Oncology Mkt",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "GEMZAR    LLY:row_5",
                    "ALIMTA    LLY:row_5",
                    "ZE FEI(Generic Gemzar):row_5",
                    "YU JIE(Generic Gemzar):row_5",
                    "FU AN(Generic Gemzar):row_5",
                    "Total Generic Gemcitabine(Generic Gemzar):row_5",
                    "PU LAI LE(Generic Alimta):row_5",
                    "SAI ZHEN(Generic Alimta):row_5",
                    "Total Generic Pemetrexed(Generic Alimta):row_5",
                    "TAXOTERE    AVS:row_5",
                    "Total Generic Docetaxel(Generic Taxotere):row_5",
                    "TAXOL    BMS:row_5",
                    "ABRAXANE    CC5:row_5",
                    "LI PU SU    JVY:row_5",
                    "ANZATAX    H1A:row_5",
                    "All Other Generic Paclitaxel:row_5",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "mCRC 3L Market (Relevant)_CHPA_ BRAND_1_MAPPING",
        "description": "192-195",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["hangzhou"]
      },
      "sliders": [
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Hangzhou (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Hangzhou (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Hangzhou (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors Cash SOM Trends in Hangzhou",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Total mCRC 3L Market (Relevant)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "ELUNATE            LLY:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "AI TAN             JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "AO XIN TAN         FKU:row_5",
                    "Total Generic Oxaliplatin(Generic Eloxatin):row_5",
                    "XELODA             ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "CAMPTO             PFZ:row_5",
                    "Total Generic Irinotecan(Generic Campto):row_5",
                    "SAI WEI JIAN       NJ2:row_5",
                    "ZHONGREN FU AN     S2H:row_5",
                    "Total Generic Fluorouracil(Generic ZHONGREN FU AN):row_5",
                    "FTORAFUR           FKU:row_5",
                    "Generic Tegafur:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "mCRC 3L Market (Indication)_CHPA_ BRAND_1_MAPPING",
        "description": "197-200",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["hangzhou"]
      },
      "sliders": [
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Hangzhou (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Hangzhou (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Hangzhou (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors Cash SOM Trends in Hangzhou",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Total mCRC 3L Market (Indication)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "ELUNATE            LLY:row_5",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "Tyvyt _CHPA_ BRAND_1_MAPPING",
        "description": "202-206",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["hangzhou"]
      },
      "sliders": [
        {
          "title": "Key Competitors DOT/CASH Performance in Hangzhou (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Key Competitors DOT/CASH Performance in Hangzhou (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Key Competitors DOT/CASH Performance in Hangzhou (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "TYVYT and Key Competitors Cash SOM Trends in Hangzhou Oncology market",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Oncology Market (L01)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "TYVYT and Key Competitors Cash SOM Trends in Hangzhou PD-1 market",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "PD-1 Market",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "ONCOLOGY_CHPA_ BRAND_1_MAPPING",
        "description": "207,209-215",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["nanjing"]
      },
      "sliders": [
        {
          "title": "NJ",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [

            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Nanjing (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Nanjing (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Nanjing (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Nanjing (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Nanjing (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Nanjing (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash SOM Trends in Nanjing",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Oncology Mkt",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "GEMZAR    LLY:row_5",
                    "ALIMTA    LLY:row_5",
                    "ZE FEI(Generic Gemzar):row_5",
                    "YU JIE(Generic Gemzar):row_5",
                    "FU AN(Generic Gemzar):row_5",
                    "Total Generic Gemcitabine(Generic Gemzar):row_5",
                    "PU LAI LE(Generic Alimta):row_5",
                    "SAI ZHEN(Generic Alimta):row_5",
                    "Total Generic Pemetrexed(Generic Alimta):row_5",
                    "TAXOTERE    AVS:row_5",
                    "Total Generic Docetaxel(Generic Taxotere):row_5",
                    "TAXOL    BMS:row_5",
                    "ABRAXANE    CC5:row_5",
                    "LI PU SU    JVY:row_5",
                    "ANZATAX    H1A:row_5",
                    "All Other Generic Paclitaxel:row_5",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "mCRC 3L Market (Relevant)_CHPA_ BRAND_1_MAPPING",
        "description": "217-220",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["nanjing"]
      },
      "sliders": [
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Nanjing (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Nanjing (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Nanjing (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors Cash SOM Trends in Nanjing",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Total mCRC 3L Market (Relevant)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "ELUNATE            LLY:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "AI TAN             JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "AO XIN TAN         FKU:row_5",
                    "Total Generic Oxaliplatin(Generic Eloxatin):row_5",
                    "XELODA             ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "CAMPTO             PFZ:row_5",
                    "Total Generic Irinotecan(Generic Campto):row_5",
                    "SAI WEI JIAN       NJ2:row_5",
                    "ZHONGREN FU AN     S2H:row_5",
                    "Total Generic Fluorouracil(Generic ZHONGREN FU AN):row_5",
                    "FTORAFUR           FKU:row_5",
                    "Generic Tegafur:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "mCRC 3L Market (Indication)_CHPA_ BRAND_1_MAPPING",
        "description": "222-225",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["nanjing"]
      },
      "sliders": [
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Nanjing (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Nanjing (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Nanjing (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors Cash SOM Trends in Nanjing",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Total mCRC 3L Market (Indication)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "ELUNATE            LLY:row_5",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "Tyvyt _CHPA_ BRAND_1_MAPPING",
        "description": "227-231",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["nanjing"]
      },
      "sliders": [
        {
          "title": "Key Competitors DOT/CASH Performance in Nanjing (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Key Competitors DOT/CASH Performance in Nanjing (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Key Competitors DOT/CASH Performance in Nanjing (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "TYVYT and Key Competitors Cash SOM Trends in Nanjing Oncology market",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Oncology Market (L01)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "TYVYT and Key Competitors Cash SOM Trends in Nanjing PD-1 market",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "PD-1 Market",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "ONCOLOGY_CHPA_ BRAND_1_MAPPING",
        "description": "232,234-240",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["suzhou"]
      },
      "sliders": [
        {
          "title": "SZ",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [

            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Suzhou (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Suzhou (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Suzhou (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Suzhou (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Suzhou (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Suzhou (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash SOM Trends in Suzhou",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Oncology Mkt",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "GEMZAR    LLY:row_5",
                    "ALIMTA    LLY:row_5",
                    "ZE FEI(Generic Gemzar):row_5",
                    "YU JIE(Generic Gemzar):row_5",
                    "FU AN(Generic Gemzar):row_5",
                    "Total Generic Gemcitabine(Generic Gemzar):row_5",
                    "PU LAI LE(Generic Alimta):row_5",
                    "SAI ZHEN(Generic Alimta):row_5",
                    "Total Generic Pemetrexed(Generic Alimta):row_5",
                    "TAXOTERE    AVS:row_5",
                    "Total Generic Docetaxel(Generic Taxotere):row_5",
                    "TAXOL    BMS:row_5",
                    "ABRAXANE    CC5:row_5",
                    "LI PU SU    JVY:row_5",
                    "ANZATAX    H1A:row_5",
                    "All Other Generic Paclitaxel:row_5",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "mCRC 3L Market (Relevant)_CHPA_ BRAND_1_MAPPING",
        "description": "242-245",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["suzhou"]
      },
      "sliders": [
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Suzhou (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Suzhou (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Suzhou (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors Cash SOM Trends in Suzhou",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Total mCRC 3L Market (Relevant)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "ELUNATE            LLY:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "AI TAN             JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "AO XIN TAN         FKU:row_5",
                    "Total Generic Oxaliplatin(Generic Eloxatin):row_5",
                    "XELODA             ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "CAMPTO             PFZ:row_5",
                    "Total Generic Irinotecan(Generic Campto):row_5",
                    "SAI WEI JIAN       NJ2:row_5",
                    "ZHONGREN FU AN     S2H:row_5",
                    "Total Generic Fluorouracil(Generic ZHONGREN FU AN):row_5",
                    "FTORAFUR           FKU:row_5",
                    "Generic Tegafur:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "mCRC 3L Market (Indication)_CHPA_ BRAND_1_MAPPING",
        "description": "247-250",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["suzhou"]
      },
      "sliders": [
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Suzhou (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Suzhou (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Suzhou (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors Cash SOM Trends in Suzhou",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Total mCRC 3L Market (Indication)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "ELUNATE            LLY:row_5",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "Tyvyt _CHPA_ BRAND_1_MAPPING",
        "description": "252-256",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["suzhou"]
      },
      "sliders": [
        {
          "title": "Key Competitors DOT/CASH Performance in Suzhou (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Key Competitors DOT/CASH Performance in Suzhou (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Key Competitors DOT/CASH Performance in Suzhou (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "TYVYT and Key Competitors Cash SOM Trends in Suzhou Oncology market",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Oncology Market (L01)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "TYVYT and Key Competitors Cash SOM Trends in Suzhou PD-1 market",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "PD-1 Market",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "ONCOLOGY_CHPA_ BRAND_1_MAPPING",
        "description": "257,259-265",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["chengdu"]
      },
      "sliders": [
        {
          "title": "CD",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [

            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Chengdu (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Chengdu (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Chengdu (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Chengdu (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Chengdu (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Chengdu (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash SOM Trends in Chengdu",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Oncology Mkt",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "GEMZAR    LLY:row_5",
                    "ALIMTA    LLY:row_5",
                    "ZE FEI(Generic Gemzar):row_5",
                    "YU JIE(Generic Gemzar):row_5",
                    "FU AN(Generic Gemzar):row_5",
                    "Total Generic Gemcitabine(Generic Gemzar):row_5",
                    "PU LAI LE(Generic Alimta):row_5",
                    "SAI ZHEN(Generic Alimta):row_5",
                    "Total Generic Pemetrexed(Generic Alimta):row_5",
                    "TAXOTERE    AVS:row_5",
                    "Total Generic Docetaxel(Generic Taxotere):row_5",
                    "TAXOL    BMS:row_5",
                    "ABRAXANE    CC5:row_5",
                    "LI PU SU    JVY:row_5",
                    "ANZATAX    H1A:row_5",
                    "All Other Generic Paclitaxel:row_5",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "mCRC 3L Market (Relevant)_CHPA_ BRAND_1_MAPPING",
        "description": "267-270",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["chengdu"]
      },
      "sliders": [
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Chengdu (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Chengdu (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Chengdu (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors Cash SOM Trends in Chengdu",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Total mCRC 3L Market (Relevant)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "ELUNATE            LLY:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "AI TAN             JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "AO XIN TAN         FKU:row_5",
                    "Total Generic Oxaliplatin(Generic Eloxatin):row_5",
                    "XELODA             ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "CAMPTO             PFZ:row_5",
                    "Total Generic Irinotecan(Generic Campto):row_5",
                    "SAI WEI JIAN       NJ2:row_5",
                    "ZHONGREN FU AN     S2H:row_5",
                    "Total Generic Fluorouracil(Generic ZHONGREN FU AN):row_5",
                    "FTORAFUR           FKU:row_5",
                    "Generic Tegafur:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "mCRC 3L Market (Indication)_CHPA_ BRAND_1_MAPPING",
        "description": "272-275",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["chengdu"]
      },
      "sliders": [
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Chengdu (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Chengdu (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Chengdu (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors Cash SOM Trends in Chengdu",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Total mCRC 3L Market (Indication)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "ELUNATE            LLY:row_5",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "Tyvyt _CHPA_ BRAND_1_MAPPING",
        "description": "277-281",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["chengdu"]
      },
      "sliders": [
        {
          "title": "Key Competitors DOT/CASH Performance in Chengdu (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Key Competitors DOT/CASH Performance in Chengdu (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Key Competitors DOT/CASH Performance in Chengdu (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "TYVYT and Key Competitors Cash SOM Trends in Chengdu Oncology market",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Oncology Market (L01)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "TYVYT and Key Competitors Cash SOM Trends in Chengdu PD-1 market",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "PD-1 Market",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "ONCOLOGY_CHPA_ BRAND_1_MAPPING",
        "description": "282,284-290",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["ningbo"]
      },
      "sliders": [
        {
          "title": "NB",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [

            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Ningbo (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Ningbo (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Ningbo (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Ningbo (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Ningbo (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Ningbo (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash SOM Trends in Ningbo",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Oncology Mkt",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "GEMZAR    LLY:row_5",
                    "ALIMTA    LLY:row_5",
                    "ZE FEI(Generic Gemzar):row_5",
                    "YU JIE(Generic Gemzar):row_5",
                    "FU AN(Generic Gemzar):row_5",
                    "Total Generic Gemcitabine(Generic Gemzar):row_5",
                    "PU LAI LE(Generic Alimta):row_5",
                    "SAI ZHEN(Generic Alimta):row_5",
                    "Total Generic Pemetrexed(Generic Alimta):row_5",
                    "TAXOTERE    AVS:row_5",
                    "Total Generic Docetaxel(Generic Taxotere):row_5",
                    "TAXOL    BMS:row_5",
                    "ABRAXANE    CC5:row_5",
                    "LI PU SU    JVY:row_5",
                    "ANZATAX    H1A:row_5",
                    "All Other Generic Paclitaxel:row_5",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "mCRC 3L Market (Relevant)_CHPA_ BRAND_1_MAPPING",
        "description": "292-295",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["ningbo"]
      },
      "sliders": [
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Ningbo (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Ningbo (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Ningbo (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors Cash SOM Trends in Ningbo",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Total mCRC 3L Market (Relevant)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "ELUNATE            LLY:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "AI TAN             JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "AO XIN TAN         FKU:row_5",
                    "Total Generic Oxaliplatin(Generic Eloxatin):row_5",
                    "XELODA             ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "CAMPTO             PFZ:row_5",
                    "Total Generic Irinotecan(Generic Campto):row_5",
                    "SAI WEI JIAN       NJ2:row_5",
                    "ZHONGREN FU AN     S2H:row_5",
                    "Total Generic Fluorouracil(Generic ZHONGREN FU AN):row_5",
                    "FTORAFUR           FKU:row_5",
                    "Generic Tegafur:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "mCRC 3L Market (Indication)_CHPA_ BRAND_1_MAPPING",
        "description": "297-300",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["ningbo"]
      },
      "sliders": [
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Ningbo (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Ningbo (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Ningbo (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors Cash SOM Trends in Ningbo",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Total mCRC 3L Market (Indication)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "ELUNATE            LLY:row_5",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "Tyvyt _CHPA_ BRAND_1_MAPPING",
        "description": "302-306",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["ningbo"]
      },
      "sliders": [
        {
          "title": "Key Competitors DOT/CASH Performance in Ningbo (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Key Competitors DOT/CASH Performance in Ningbo (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Key Competitors DOT/CASH Performance in Ningbo (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "TYVYT and Key Competitors Cash SOM Trends in Ningbo Oncology market",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Oncology Market (L01)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "TYVYT and Key Competitors Cash SOM Trends in Ningbo PD-1 market",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "PD-1 Market",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "ONCOLOGY_CHPA_ BRAND_1_MAPPING",
        "description": "307,309-315",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["wuhan"]
      },
      "sliders": [
        {
          "title": "WH",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [

            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Wuhan (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Wuhan (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Wuhan (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Wuhan (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Wuhan (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Wuhan (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash SOM Trends in Wuhan",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Oncology Mkt",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "GEMZAR    LLY:row_5",
                    "ALIMTA    LLY:row_5",
                    "ZE FEI(Generic Gemzar):row_5",
                    "YU JIE(Generic Gemzar):row_5",
                    "FU AN(Generic Gemzar):row_5",
                    "Total Generic Gemcitabine(Generic Gemzar):row_5",
                    "PU LAI LE(Generic Alimta):row_5",
                    "SAI ZHEN(Generic Alimta):row_5",
                    "Total Generic Pemetrexed(Generic Alimta):row_5",
                    "TAXOTERE    AVS:row_5",
                    "Total Generic Docetaxel(Generic Taxotere):row_5",
                    "TAXOL    BMS:row_5",
                    "ABRAXANE    CC5:row_5",
                    "LI PU SU    JVY:row_5",
                    "ANZATAX    H1A:row_5",
                    "All Other Generic Paclitaxel:row_5",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "mCRC 3L Market (Relevant)_CHPA_ BRAND_1_MAPPING",
        "description": "317-320",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["wuhan"]
      },
      "sliders": [
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Wuhan (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Wuhan (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Wuhan (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors Cash SOM Trends in Wuhan",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Total mCRC 3L Market (Relevant)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "ELUNATE            LLY:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "AI TAN             JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "AO XIN TAN         FKU:row_5",
                    "Total Generic Oxaliplatin(Generic Eloxatin):row_5",
                    "XELODA             ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "CAMPTO             PFZ:row_5",
                    "Total Generic Irinotecan(Generic Campto):row_5",
                    "SAI WEI JIAN       NJ2:row_5",
                    "ZHONGREN FU AN     S2H:row_5",
                    "Total Generic Fluorouracil(Generic ZHONGREN FU AN):row_5",
                    "FTORAFUR           FKU:row_5",
                    "Generic Tegafur:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "mCRC 3L Market (Indication)_CHPA_ BRAND_1_MAPPING",
        "description": "322-325",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["wuhan"]
      },
      "sliders": [
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Wuhan (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Wuhan (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Wuhan (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors Cash SOM Trends in Wuhan",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Total mCRC 3L Market (Indication)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "ELUNATE            LLY:row_5",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "Tyvyt _CHPA_ BRAND_1_MAPPING",
        "description": "327-331",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["wuhan"]
      },
      "sliders": [
        {
          "title": "Key Competitors DOT/CASH Performance in Wuhan (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Key Competitors DOT/CASH Performance in Wuhan (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Key Competitors DOT/CASH Performance in Wuhan (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "TYVYT and Key Competitors Cash SOM Trends in Wuhan Oncology market",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Oncology Market (L01)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "TYVYT and Key Competitors Cash SOM Trends in Wuhan PD-1 market",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "PD-1 Market",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "ONCOLOGY_CHPA_ BRAND_1_MAPPING",
        "description": "332,334-340",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["shenyang"]
      },
      "sliders": [
        {
          "title": "SY",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [

            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Shenyang (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Shenyang (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Shenyang (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Shenyang (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Shenyang (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Shenyang (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash SOM Trends in Shenyang",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Oncology Mkt",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "GEMZAR    LLY:row_5",
                    "ALIMTA    LLY:row_5",
                    "ZE FEI(Generic Gemzar):row_5",
                    "YU JIE(Generic Gemzar):row_5",
                    "FU AN(Generic Gemzar):row_5",
                    "Total Generic Gemcitabine(Generic Gemzar):row_5",
                    "PU LAI LE(Generic Alimta):row_5",
                    "SAI ZHEN(Generic Alimta):row_5",
                    "Total Generic Pemetrexed(Generic Alimta):row_5",
                    "TAXOTERE    AVS:row_5",
                    "Total Generic Docetaxel(Generic Taxotere):row_5",
                    "TAXOL    BMS:row_5",
                    "ABRAXANE    CC5:row_5",
                    "LI PU SU    JVY:row_5",
                    "ANZATAX    H1A:row_5",
                    "All Other Generic Paclitaxel:row_5",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "mCRC 3L Market (Relevant)_CHPA_ BRAND_1_MAPPING",
        "description": "342-345",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["shenyang"]
      },
      "sliders": [
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Shenyang (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Shenyang (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Shenyang (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors Cash SOM Trends in Shenyang",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Total mCRC 3L Market (Relevant)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "ELUNATE            LLY:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "AI TAN             JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "AO XIN TAN         FKU:row_5",
                    "Total Generic Oxaliplatin(Generic Eloxatin):row_5",
                    "XELODA             ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "CAMPTO             PFZ:row_5",
                    "Total Generic Irinotecan(Generic Campto):row_5",
                    "SAI WEI JIAN       NJ2:row_5",
                    "ZHONGREN FU AN     S2H:row_5",
                    "Total Generic Fluorouracil(Generic ZHONGREN FU AN):row_5",
                    "FTORAFUR           FKU:row_5",
                    "Generic Tegafur:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "mCRC 3L Market (Indication)_CHPA_ BRAND_1_MAPPING",
        "description": "347-350",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["shenyang"]
      },
      "sliders": [
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Shenyang (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Shenyang (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Shenyang (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors Cash SOM Trends in Shenyang",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Total mCRC 3L Market (Indication)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "ELUNATE            LLY:row_5",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "Tyvyt _CHPA_ BRAND_1_MAPPING",
        "description": "352-356",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["shenyang"]
      },
      "sliders": [
        {
          "title": "Key Competitors DOT/CASH Performance in Shenyang (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Key Competitors DOT/CASH Performance in Shenyang (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Key Competitors DOT/CASH Performance in Shenyang (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "TYVYT and Key Competitors Cash SOM Trends in Shenyang Oncology market",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Oncology Market (L01)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "TYVYT and Key Competitors Cash SOM Trends in Shenyang PD-1 market",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "PD-1 Market",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "ONCOLOGY_CHPA_ BRAND_1_MAPPING",
        "description": "357,359-365",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["chongqing"]
      },
      "sliders": [
        {
          "title": "CQ",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [

            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Chongqing (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Chongqing (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Chongqing (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Chongqing (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Chongqing (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Chongqing (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash SOM Trends in Chongqing",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Oncology Mkt",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "GEMZAR    LLY:row_5",
                    "ALIMTA    LLY:row_5",
                    "ZE FEI(Generic Gemzar):row_5",
                    "YU JIE(Generic Gemzar):row_5",
                    "FU AN(Generic Gemzar):row_5",
                    "Total Generic Gemcitabine(Generic Gemzar):row_5",
                    "PU LAI LE(Generic Alimta):row_5",
                    "SAI ZHEN(Generic Alimta):row_5",
                    "Total Generic Pemetrexed(Generic Alimta):row_5",
                    "TAXOTERE    AVS:row_5",
                    "Total Generic Docetaxel(Generic Taxotere):row_5",
                    "TAXOL    BMS:row_5",
                    "ABRAXANE    CC5:row_5",
                    "LI PU SU    JVY:row_5",
                    "ANZATAX    H1A:row_5",
                    "All Other Generic Paclitaxel:row_5",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "mCRC 3L Market (Relevant)_CHPA_ BRAND_1_MAPPING",
        "description": "367-370",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["chongqing"]
      },
      "sliders": [
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Chongqing (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Chongqing (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Chongqing (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors Cash SOM Trends in Chongqing",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Total mCRC 3L Market (Relevant)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "ELUNATE            LLY:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "AI TAN             JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "AO XIN TAN         FKU:row_5",
                    "Total Generic Oxaliplatin(Generic Eloxatin):row_5",
                    "XELODA             ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "CAMPTO             PFZ:row_5",
                    "Total Generic Irinotecan(Generic Campto):row_5",
                    "SAI WEI JIAN       NJ2:row_5",
                    "ZHONGREN FU AN     S2H:row_5",
                    "Total Generic Fluorouracil(Generic ZHONGREN FU AN):row_5",
                    "FTORAFUR           FKU:row_5",
                    "Generic Tegafur:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "mCRC 3L Market (Indication)_CHPA_ BRAND_1_MAPPING",
        "description": "372-375",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["chongqing"]
      },
      "sliders": [
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Chongqing (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Chongqing (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Chongqing (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors Cash SOM Trends in Chongqing",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Total mCRC 3L Market (Indication)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "ELUNATE            LLY:row_5",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "Tyvyt _CHPA_ BRAND_1_MAPPING",
        "description": "377-381",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["chongqing"]
      },
      "sliders": [
        {
          "title": "Key Competitors DOT/CASH Performance in Chongqing (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Key Competitors DOT/CASH Performance in Chongqing (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Key Competitors DOT/CASH Performance in Chongqing (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "TYVYT and Key Competitors Cash SOM Trends in Chongqing Oncology market",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Oncology Market (L01)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "TYVYT and Key Competitors Cash SOM Trends in Chongqing PD-1 market",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "PD-1 Market",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "ONCOLOGY_CHPA_ BRAND_1_MAPPING",
        "description": "382,384-390",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["jinan"]
      },
      "sliders": [
        {
          "title": "JN",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [

            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Jinan (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Jinan (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Jinan (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Jinan (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Jinan (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Jinan (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash SOM Trends in Jinan",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Oncology Mkt",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "GEMZAR    LLY:row_5",
                    "ALIMTA    LLY:row_5",
                    "ZE FEI(Generic Gemzar):row_5",
                    "YU JIE(Generic Gemzar):row_5",
                    "FU AN(Generic Gemzar):row_5",
                    "Total Generic Gemcitabine(Generic Gemzar):row_5",
                    "PU LAI LE(Generic Alimta):row_5",
                    "SAI ZHEN(Generic Alimta):row_5",
                    "Total Generic Pemetrexed(Generic Alimta):row_5",
                    "TAXOTERE    AVS:row_5",
                    "Total Generic Docetaxel(Generic Taxotere):row_5",
                    "TAXOL    BMS:row_5",
                    "ABRAXANE    CC5:row_5",
                    "LI PU SU    JVY:row_5",
                    "ANZATAX    H1A:row_5",
                    "All Other Generic Paclitaxel:row_5",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "mCRC 3L Market (Relevant)_CHPA_ BRAND_1_MAPPING",
        "description": "392-395",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["jinan"]
      },
      "sliders": [
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Jinan (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Jinan (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Jinan (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors Cash SOM Trends in Jinan",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Total mCRC 3L Market (Relevant)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "ELUNATE            LLY:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "AI TAN             JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "AO XIN TAN         FKU:row_5",
                    "Total Generic Oxaliplatin(Generic Eloxatin):row_5",
                    "XELODA             ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "CAMPTO             PFZ:row_5",
                    "Total Generic Irinotecan(Generic Campto):row_5",
                    "SAI WEI JIAN       NJ2:row_5",
                    "ZHONGREN FU AN     S2H:row_5",
                    "Total Generic Fluorouracil(Generic ZHONGREN FU AN):row_5",
                    "FTORAFUR           FKU:row_5",
                    "Generic Tegafur:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "mCRC 3L Market (Indication)_CHPA_ BRAND_1_MAPPING",
        "description": "397-400",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["jinan"]
      },
      "sliders": [
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Jinan (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Jinan (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Jinan (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors Cash SOM Trends in Jinan",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Total mCRC 3L Market (Indication)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "ELUNATE            LLY:row_5",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "Tyvyt _CHPA_ BRAND_1_MAPPING",
        "description": "402-406",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["jinan"]
      },
      "sliders": [
        {
          "title": "Key Competitors DOT/CASH Performance in Jinan (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Key Competitors DOT/CASH Performance in Jinan (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Key Competitors DOT/CASH Performance in Jinan (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "TYVYT and Key Competitors Cash SOM Trends in Jinan Oncology market",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Oncology Market (L01)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "TYVYT and Key Competitors Cash SOM Trends in Jinan PD-1 market",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "PD-1 Market",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "ONCOLOGY_CHPA_ BRAND_1_MAPPING",
        "description": "407,409-415",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["tianjin"]
      },
      "sliders": [
        {
          "title": "TJ",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [

            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Tianjin (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Tianjin (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Tianjin (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Tianjin (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Tianjin (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Tianjin (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash SOM Trends in Tianjin",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Oncology Mkt",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "GEMZAR    LLY:row_5",
                    "ALIMTA    LLY:row_5",
                    "ZE FEI(Generic Gemzar):row_5",
                    "YU JIE(Generic Gemzar):row_5",
                    "FU AN(Generic Gemzar):row_5",
                    "Total Generic Gemcitabine(Generic Gemzar):row_5",
                    "PU LAI LE(Generic Alimta):row_5",
                    "SAI ZHEN(Generic Alimta):row_5",
                    "Total Generic Pemetrexed(Generic Alimta):row_5",
                    "TAXOTERE    AVS:row_5",
                    "Total Generic Docetaxel(Generic Taxotere):row_5",
                    "TAXOL    BMS:row_5",
                    "ABRAXANE    CC5:row_5",
                    "LI PU SU    JVY:row_5",
                    "ANZATAX    H1A:row_5",
                    "All Other Generic Paclitaxel:row_5",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "mCRC 3L Market (Relevant)_CHPA_ BRAND_1_MAPPING",
        "description": "417-420",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["tianjin"]
      },
      "sliders": [
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Tianjin (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Tianjin (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Tianjin (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors Cash SOM Trends in Tianjin",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Total mCRC 3L Market (Relevant)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "ELUNATE            LLY:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "AI TAN             JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "AO XIN TAN         FKU:row_5",
                    "Total Generic Oxaliplatin(Generic Eloxatin):row_5",
                    "XELODA             ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "CAMPTO             PFZ:row_5",
                    "Total Generic Irinotecan(Generic Campto):row_5",
                    "SAI WEI JIAN       NJ2:row_5",
                    "ZHONGREN FU AN     S2H:row_5",
                    "Total Generic Fluorouracil(Generic ZHONGREN FU AN):row_5",
                    "FTORAFUR           FKU:row_5",
                    "Generic Tegafur:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "mCRC 3L Market (Indication)_CHPA_ BRAND_1_MAPPING",
        "description": "422-425",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["tianjin"]
      },
      "sliders": [
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Tianjin (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Tianjin (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Tianjin (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors Cash SOM Trends in Tianjin",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Total mCRC 3L Market (Indication)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "ELUNATE            LLY:row_5",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "Tyvyt _CHPA_ BRAND_1_MAPPING",
        "description": "427-431",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["tianjin"]
      },
      "sliders": [
        {
          "title": "Key Competitors DOT/CASH Performance in Tianjin (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Key Competitors DOT/CASH Performance in Tianjin (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Key Competitors DOT/CASH Performance in Tianjin (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "TYVYT and Key Competitors Cash SOM Trends in Tianjin Oncology market",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Oncology Market (L01)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "TYVYT and Key Competitors Cash SOM Trends in Tianjin PD-1 market",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "PD-1 Market",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "ONCOLOGY_CHPA_ BRAND_1_MAPPING",
        "description": "434-440",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["zhengzhou"]
      },
      "sliders": [
        {
          "title": "ZZ",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [

            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Zhengzhou (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Zhengzhou (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in Zhengzhou (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_7",
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Zhengzhou (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Zhengzhou (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors MG Performance in Zhengzhou (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "Mg(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Lilly Relevant Mkt:row_7",
                    "Lilly Relevant TKI Mkt:row_7",
                    "Lilly Relevant chemo Mkt:row_7",
                    "Lilly Relevant Branded Chemo Mkt:row_7",
                    "GEMZAR    LLY:row_2",
                    "ALIMTA    LLY:row_2",
                    "ZE FEI(Generic Gemzar):row_4",
                    "YU JIE(Generic Gemzar):row_4",
                    "FU AN(Generic Gemzar):row_4",
                    "Total Generic Gemcitabine(Generic Gemzar):row_4",
                    "PU LAI LE(Generic Alimta):row_3",
                    "SAI ZHEN(Generic Alimta):row_3",
                    "Total Generic Pemetrexed(Generic Alimta):row_3",
                    "TAXOTERE    AVS:row_3",
                    "Total Generic Docetaxel(Generic Taxotere):row_3",
                    "TAXOL    BMS:row_4",
                    "ABRAXANE    CC5:row_4",
                    "LI PU SU    JVY:row_4",
                    "ANZATAX    H1A:row_4",
                    "All Other Generic Paclitaxel:row_4",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Gemzar and Alimta Key Competitors Cash SOM Trends in Zhengzhou",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Oncology Mkt",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "GEMZAR    LLY:row_5",
                    "ALIMTA    LLY:row_5",
                    "ZE FEI(Generic Gemzar):row_5",
                    "YU JIE(Generic Gemzar):row_5",
                    "FU AN(Generic Gemzar):row_5",
                    "Total Generic Gemcitabine(Generic Gemzar):row_5",
                    "PU LAI LE(Generic Alimta):row_5",
                    "SAI ZHEN(Generic Alimta):row_5",
                    "Total Generic Pemetrexed(Generic Alimta):row_5",
                    "TAXOTERE    AVS:row_5",
                    "Total Generic Docetaxel(Generic Taxotere):row_5",
                    "TAXOL    BMS:row_5",
                    "ABRAXANE    CC5:row_5",
                    "LI PU SU    JVY:row_5",
                    "ANZATAX    H1A:row_5",
                    "All Other Generic Paclitaxel:row_5",
                    "XELODA    ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "NAVELBINE    P.F:row_5",
                    "Total Generic Vinorelbine(Generic Navelbine):row_5",
                    "IRESSA    AZN:row_5",
                    "Generic Gefitinib- Generic Iressa:row_5",
                    "TARCEVA    ROC:row_5",
                    "CONMANA    Z1B:row_5",
                    "XALKORI    PFZ:row_5",
                    "AVASTIN    GTC:row_5",
                    "GIOTRIF    B.I:row_5",
                    "TAGRISSO    AZN:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "mCRC 3L Market (Relevant)_CHPA_ BRAND_1_MAPPING",
        "description": "442-445",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["zhengzhou"]
      },
      "sliders": [
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Zhengzhou (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Zhengzhou (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Zhengzhou (QTR) ",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Relevant):row_7",
                    "AI HENG            JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "Other Oxaliplatin:row_5",
                    "XELODA             ROC:row_5",
                    "Other Capecitabine:row_5",
                    "AI LI              JSH:row_5",
                    "CAMPTO             PFZ:row_5",
                    "Other Irinotecan:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "FLUOROURACIL:row_5",
                    "RALTITREXED:row_5",
                    "FANG KE            HNQ:row_5",
                    "Other Tegafur:row_5",
                    "STIVARGA           BY6:row_5",
                    "AI TAN             JSH:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors Cash SOM Trends in Zhengzhou",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Total mCRC 3L Market (Relevant)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "ELUNATE            LLY:row_5",
                    "AVASTIN            GTC:row_5",
                    "ERBITUX            MCK:row_5",
                    "AI TAN             JSH:row_5",
                    "ELOXATIN           SG9:row_5",
                    "AO XIN TAN         FKU:row_5",
                    "Total Generic Oxaliplatin(Generic Eloxatin):row_5",
                    "XELODA             ROC:row_5",
                    "Total Generic Capecitabine(Generic Xeloda):row_5",
                    "CAMPTO             PFZ:row_5",
                    "Total Generic Irinotecan(Generic Campto):row_5",
                    "SAI WEI JIAN       NJ2:row_5",
                    "ZHONGREN FU AN     S2H:row_5",
                    "Total Generic Fluorouracil(Generic ZHONGREN FU AN):row_5",
                    "FTORAFUR           FKU:row_5",
                    "Generic Tegafur:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "mCRC 3L Market (Indication)_CHPA_ BRAND_1_MAPPING",
        "description": "447-450",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["zhengzhou"]
      },
      "sliders": [
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Zhengzhou (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Zhengzhou (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors DOT/CASH Performance in Zhengzhou (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM(%):col_common3",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "Growth(%):col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Total mCRC 3L Market (Indication):row_7",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Elunate and Key Competitors Cash SOM Trends in Zhengzhou",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Total mCRC 3L Market (Indication)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "ELUNATE            LLY:row_5",
                    "ERBITUX            MCK:row_5",
                    "STIVARGA           BY6:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    },
    {
      "filter": {
        "name": "Tyvyt _CHPA_ BRAND_1_MAPPING",
        "description": "452-456",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phCityFilterImpl",
        "filt": ["zhengzhou"]
      },
      "sliders": [
        {
          "title": "Key Competitors DOT/CASH Performance in Zhengzhou (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "MAT Q#qtime8#:timeline_2", "MAT Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Key Competitors DOT/CASH Performance in Zhengzhou (YTD)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "YTD Q#qtime8#:timeline_2", "YTD Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "Key Competitors DOT/CASH Performance in Zhengzhou (QTR)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB:col_common1",
                    "SOM in Oncology Market (L01):col_common3",
                    "SOM in PD-1 Market:col_common3",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              },
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityBaseTableCommonTable",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 300, 81, 81
                ],
                "timeline": [
                  "QTR Q#qtime8#:timeline_2", "QTR Q#qtime4#:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "MG(Mn):col_common1",
                    "YOY GR:col_common3"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Market (L01):row_7",
                    "PD-1 Market:row_7",
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "TYVYT and Key Competitors Cash SOM Trends in Zhengzhou Oncology market",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "Oncology Market (L01)",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        },
        {
          "title": "TYVYT and Key Competitors Cash SOM Trends in Zhengzhou PD-1 market",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phContentTable.phCityLineChartCommonTable",
                "mkt_display": "PD-1 Market",
                "mkt_col": "RMB",
                "pos": [
                  30, 60, 600, 400
                ],
                "timeline": [
                  "Q#qtime1#:timeline_1",
                  "Q#qtime2#:timeline_1",
                  "Q#qtime3#:timeline_1",
                  "Q#qtime4#:timeline_1",
                  "Q#qtime5#:timeline_1",
                  "Q#qtime6#:timeline_1",
                  "Q#qtime7#:timeline_1",
                  "Q#qtime8#:timeline_1"
                ],
                "col": {
                  "title" : ":col_title_chart",
                  "count" : [
                    "SOM%:col_chart"
                  ]
                },
                "row": {
                  "title" : ":row_title_chart",
                  "display_name" : [
                    "TECENTRIQ          GTC:row_5",
                    "KEYTRUDA           MSD:row_5"
                  ]
                }
              }
            ]
          }
        }
      ]
    }
  ]
}